Holen Sie sich die Stockscreener-App
15.35
2.06%
0.31
Schlusskurs vom Vortag:
$15.04
Offen:
$14.99
24-Stunden-Volumen:
164.56K
Relative Volume:
0.86
Marktkapitalisierung:
$560.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-8.63%
1M Leistung:
+9.33%
6M Leistung:
+53.65%
1J Leistung:
-27.59%
1-Tages-Spanne:
$14.11
$15.76
1-Wochen-Bereich:
$14.11
$17.99
52-Wochen-Spanne:
$7.13
$29.74
Rapport Therapeutics Inc Stock (RAPP) Company Profile
Firmenname
Rapport Therapeutics Inc
Sektor
Branche
Telefon
857-321-8020
Adresse
99 HIGH STREET, BOSTON
Vergleichen Sie RAPP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RAPP
Rapport Therapeutics Inc
|
15.35 | 597.47M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-08 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-07-02 | Eingeleitet | Jefferies | Buy |
| 2024-07-02 | Eingeleitet | Stifel | Buy |
| 2024-07-02 | Eingeleitet | TD Cowen | Buy |
Rapport Therapeutics Inc Aktie (RAPP) Neueste Nachrichten
Head-To-Head Analysis: Biofrontera (NASDAQ:BFRI) and Rapport Therapeutics (NASDAQ:RAPP) - Defense World
Evaluating Rapport Therapeutics Inc. with trendline analysisMarket Volume Summary & Short-Term Trading Opportunity Alerts - Newser
Measuring Rapport Therapeutics Inc.’s beta against major indicesPortfolio Gains Summary & Breakout Confirmation Alerts - Newser
What data driven models say about Rapport Therapeutics Inc.’s futureMarket Risk Analysis & Free Real-Time Market Sentiment Alerts - Newser
Analyzing Rapport Therapeutics Inc. with multi timeframe chartsMarket Growth Review & Detailed Earnings Play Strategies - Newser
Rapport Therapeutics Inc. stock prediction for this weekWeekly Trend Recap & Capital Efficiency Focused Ideas - Newser
Short interest data insights for Rapport Therapeutics Inc.Trade Exit Summary & Daily Technical Stock Forecast Reports - Newser
Earnings visualization tools for Rapport Therapeutics Inc.Weekly Market Report & AI Optimized Trade Strategies - Newser
Comparing Rapport Therapeutics Inc. in custom built stock radarsTrade Performance Summary & Verified Chart Pattern Trade Signals - Newser
Is Rapport Therapeutics Inc. stock poised for growthJuly 2025 Retail & Weekly High Return Stock Opportunities - Newser
Real time scanner hits for Rapport Therapeutics Inc. explainedQuarterly Trade Review & Risk Adjusted Buy/Sell Alerts - Newser
Real time breakdown of Rapport Therapeutics Inc. stock performanceMarket Trend Review & Growth Focused Stock Reports - Newser
Is this a good reentry point in Rapport Therapeutics Inc.July 2025 Final Week & Verified Momentum Stock Watchlist - Newser
Analyzing drawdowns of Rapport Therapeutics Inc. with statistical toolsEarnings Beat & Long-Term Growth Stock Strategies - Newser
Best data tools to analyze Rapport Therapeutics Inc. stockBuy Signal & Accurate Buy Signal Notifications - Newser
Should you wait for a breakout in Rapport Therapeutics Inc.July 2025 Summary & Free Daily Entry Point Trade Alerts - Newser
Is Rapport Therapeutics Inc. stock a value trap2025 Breakouts & Breakdowns & AI Powered Trade Plan Recommendations - khodrobank.com
What moving averages say about Rapport Therapeutics Inc.July 2025 Fed Impact & Smart Investment Allocation Tips - Newser
How to monitor Rapport Therapeutics Inc. with trend dashboardsPortfolio Gains Report & Accurate Buy Signal Notifications - Newser
What’s the fair value of Rapport Therapeutics Inc. stockEarnings Overview Report & Weekly Top Gainers Alerts - khodrobank.com
Will Rapport Therapeutics Inc. outperform the market2025 Dividend Review & Stepwise Trade Execution Plans - Newser
Is Rapport Therapeutics Inc. reversing from oversold territory2025 Investor Takeaways & Weekly Top Gainers Alerts - Newser
Why Rapport Therapeutics Inc. is moving todayMarket Performance Report & Growth Focused Investment Plans - Newser
Using RSI to spot recovery in Rapport Therapeutics Inc.Weekly Loss Report & Consistent Return Investment Signals - Newser
Can Rapport Therapeutics Inc. continue delivering strong returnsMarket Activity Recap & Weekly Setup with ROI Potential - khodrobank.com
Candlestick signals on Rapport Therapeutics Inc. stock todayJuly 2025 Intraday Action & Short-Term Trading Alerts - Newser
Analyst Calls: Is now the right time to enter Rapport Therapeutics Inc.Earnings Trend Report & AI Powered Trade Plan Recommendations - khodrobank.com
What are Rapport Therapeutics Inc.’s growth leversInsider Selling & Short-Term High Return Ideas - khodrobank.com
Fed Watch: Can Rapport Therapeutics Inc. withstand a market correction2025 Technical Patterns & Growth Focused Entry Reports - khodrobank.com
Bank Watch: How does Rapport Therapeutics Inc. compare to its peersTrade Ideas & Technical Buy Zone Confirmations - khodrobank.com
How does Rapport Therapeutics Inc. compare to its peersPortfolio Risk Summary & AI Forecast Swing Trade Picks - khodrobank.com
What is Rapport Therapeutics Inc. s 5 year growth outlookWeekly Gains Report & Safe Entry Zone Identification - khodrobank.com
Visual trend scoring systems applied to Rapport Therapeutics Inc.Market Performance Summary & Risk Managed Trade Strategies - Newser
What’s next for Rapport Therapeutics Inc. stockJuly 2025 Big Picture & Real-Time Buy Zone Alerts - khodrobank.com
Is it time to cut losses on Rapport Therapeutics Inc.2025 Year in Review & Verified Stock Trade Ideas - Newser
Backtesting results for Rapport Therapeutics Inc. trading strategiesTrade Ideas & Risk Controlled Swing Trade Alerts - Newser
Ranking Rapport Therapeutics Inc. among high performing stocks via toolsJuly 2025 Spike Watch & Growth Focused Stock Reports - Newser
Finanzdaten der Rapport Therapeutics Inc-Aktie (RAPP)
Es liegen keine Finanzdaten für Rapport Therapeutics Inc (RAPP) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Rapport Therapeutics Inc-Aktie (RAPP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bredt David | Chief Scientific Officer |
Jul 15 '25 |
Sale |
14.00 |
8,500 |
118,962 |
435,142 |
| Bredt David | Chief Scientific Officer |
Jun 16 '25 |
Sale |
11.00 |
8,500 |
93,522 |
443,642 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):